Kristina Nagy

Title: Kristina Nagy: Innovator in Immunomodulatory Cell Research

Introduction

Kristina Nagy is a prominent inventor based in Toronto, Canada. She has made significant contributions to the field of immunology, particularly in the development of innovative therapies for transplant tolerance. With a focus on creating solutions that minimize the need for systemic immune suppression, her work is paving the way for advancements in transplant medicine.

Latest Patents

Kristina Nagy holds 2 patents, with her latest patent titled "IMMUNOMODULATORY CELLS AND USES THEREOF." This patent describes a cell that is genetically modified to provide local immunosuppression at a transplant site when transplanted in an allogeneic host. The invention includes methods for making and using these cells, which comprise a set of transgenes. Each transgene encodes a gene product that can mitigate various immune responses, such as antigen presenting cell activation, graft attacking leukocyte activity, and local inflammatory proteins.

Career Highlights

Kristina Nagy is affiliated with Sinai Health System, where she continues her research and development efforts. Her work is instrumental in advancing the understanding of immunomodulatory cells and their applications in clinical settings.

Collaborations

Some of her notable coworkers include Andras Nagy and Jeffrey Harding, who contribute to her research initiatives and help drive innovation in the field.

Conclusion

Kristina Nagy is a trailblazer in the realm of immunomodulatory cell research, with her patents reflecting her commitment to improving transplant outcomes. Her contributions are vital to the future of immunology and transplant medicine.